Key Moments
- Equifax shares rose 1.5% in pre-market trading after reporting third-quarter 2026 adjusted EPS of $2.26, above the roughly $2.20 analyst consensus.
- Q3 2026 revenue reached $1.69 billion, in line with expectations and up 10% year-over-year, while net income increased 32% to $211.7 million.
- Despite trimming full-year revenue and EPS guidance amid ongoing mortgage market weakness, reduced short interest and a solid quarter supported the stock.
Headline Beat Lifts Shares
Equifax stock gained 1.5% in pre-open trading after the company delivered third-quarter 2026 results that were better than anticipated on the bottom line. The credit data and analytics company reported adjusted earnings per share of $2.26, topping the analyst consensus of approximately $2.20 and extending its run of consecutive quarterly beats.
Revenue for the quarter came in at $1.69 billion, matching expectations. Sales grew 10% compared with the same period a year earlier, while net income jumped 32% to $211.7 million. The performance highlighted the robustness of Equifax’s diversified operations, even as the U.S. mortgage market weakened sharply in the latter part of the quarter.
Guidance Sends Mixed Signals
The company’s outlook presented a more nuanced picture. For the fourth quarter of 2026, Equifax projected EPS of $2.07–$2.17, slightly below the Wall Street consensus of $2.18. In addition, the company reduced the midpoint of its full-year revenue forecast to $6.661 billion, pointing to continued softness in mortgage-related activity.
However, the adjustment to earnings expectations was relatively modest. Full-year adjusted EPS guidance was lowered by only $0.04 at the midpoint, a smaller reduction than some investors had anticipated. That limited cut appeared to provide reassurance that mortgage market pressures were not inflicting deeper damage on overall profitability.
| Metric | Q3 2026 Result / Guidance | Market Expectation | Commentary |
|---|---|---|---|
| Adjusted EPS | $2.26 | ≈ $2.20 | Beat estimates and extended quarterly beat streak |
| Revenue | $1.69 billion | $1.69 billion | In line with consensus, up 10% year-over-year |
| Net Income | $211.7 million | Not specified | Up 32% year-over-year |
| Q4 2026 EPS Guidance | $2.07–$2.17 | $2.18 | Slightly below consensus |
| Full-year 2026 Revenue Guidance Midpoint | $6.661 billion | Prior midpoint higher (not specified) | Trimmed on ongoing mortgage market softness |
| Full-year 2026 Adjusted EPS Guidance | Midpoint cut by $0.04 | Not specified | Smaller reduction than some investors feared |
Positioning and Analyst Actions
Technical factors also supported the move higher. Short interest in Equifax contracted by roughly 31% in the week leading up to the earnings release, signaling that a significant portion of bearish positioning had already been covered before the numbers were announced. That shift helped limit downside pressure and may have amplified the positive reaction to the earnings beat.
The gain in pre-market trading came despite a series of cautious analyst moves ahead of the report. On October 16, Oppenheimer downgraded Equifax from Outperform to Perform, highlighting mortgage market headwinds that account for about 20%–22% of the company’s revenue.
RBC Capital cut its price target before the results, while Morgan Stanley and other firms had also reduced their outlooks in recent weeks. These actions had largely been absorbed by the market prior to the earnings release, leaving the stronger-than-expected third-quarter performance as the main driver of the stock’s latest move.
Business Performance Amid Mortgage Weakness
The third-quarter update painted a picture of a company managing through a difficult sector backdrop. Equifax showed that it could expand both revenue and margins despite the pronounced slowdown in the U.S. mortgage market late in the quarter.
The Diversified Markets segment recorded 8% growth, demonstrating that other parts of the business continued to perform well and offset some of the mortgage drag. In addition, the company reported that its new product Vitality Index reached a record level above 17%, emphasizing the contribution of newer offerings to overall growth.
Market Context and Investor Takeaways
Broader equities provided little support, with the S&P 500 and Nasdaq both trading modestly lower on the day. Against that backdrop, Equifax’s pre-market rise stood out, driven primarily by company-specific news.
Overall, investors were left with a story that was better than many had feared. The combination of a clear earnings beat, relatively restrained guidance cuts, reduced short interest, and steady performance from diversified and new product areas was sufficient to lift the stock, even as the mortgage outlook remains difficult heading into year-end.





